Alzheimer's disease: Treatments and drugs - MayoClinic.com
Links shared publicly online about this topic.
- 960total visits
Alzheimer's disease: Treatments and drugs - MayoClinic.com
View full resource at mayoclinic.com
Tags: Alzheimer's Disease, Disease and Condition, Drug
Most Recently Shared on August 9, 2010 at 1:54 pm By:
Only 2 types drugs have been shown to decrease the cognitive decline in Alzheimer's patients. Get more treatment info: http://bit.ly/cMoBt2
Also Shared By:
Addiction Treatment Australia - Food Addiction
gatsprogram.com — “Food Addiction - Food Addiction is a serious disorder and cant be treated just with diets. GATS is a leader in FOOD Addiction Rehab.” View full resource at gatsprogram.com
Most Recently Shared on April 23, 2012 at 1:22 am By:
http://t.co/8PWBW1r1 FOOD ADDICTION is a disease NOT a Disgrace!
New Method May Help Detect Marker for Alzheimer’s Disease Earlier
newswise.com — “Use of a new drug to detect the beta-amyloid plaques in the brain that are hallmark signs of Alzheimer’s disease may help doctors diagnose the disease earlier, according to research that will be presented as part of the Emerging Science program (formerly known as Late-Breaking Science) at the American Academy of Neurology’s 64th Annual Meeting in New Orleans April 21 to April 28, 2012.” View full resource at newswise.com
Most Recently Shared on April 19, 2012 at 1:02 pm By:
RGNJournal Medical Journal and Nursing
@AANMember: New Method May Help Detect Marker for #Alzheimer’s #Disease Earlier http://t.co/AtBBrimK
Memory Loss Patient Education | Alzheimers Disease Guide
vitals.com — “Alzheimer's disease information and patient education guide to memory loss symptoms, diagnosis and treatment.” View full resource at vitals.com
Most Recently Shared on April 18, 2012 at 2:19 pm By:
American Academy of Neurology, and author of A Pocket Guide for the Alzheimer's Caregiver. Additionally, he is a partner at
Alabama Neurology and Sleep Medicine and Associate Clinical Professor at
the University of Alabama’s College of Community Health Sciences.
Selected as the 2008 American Academy of Neurology’s Advocate of the
Year, Dr. Potts seeks to improve the quality of life for dementia
patients and their caregivers primarily through innovative education and
through incorporating the expressive arts. Born out of his experience as
an Alzheimer’s caregiver, and nurtured through the American Academy of
Neurology’s Palatucci Advocacy Program, Dr. Potts formed
Cognitive Dynamics, a foundation dedicated to fostering the
expressive arts to improve the lives of dementia patients and their
caregivers and championing human dignity. Dr. Potts is also Medical Director of a dementia caregiver training caregiver company, Dementia Dynamics, LLC. " /> Daniel C. Potts, MD Doctor, Internist, Neurologist, Physician, and Active Health Library
Alzheimer's Disease Patient Education | Diagnosis and Treatment
vitals.com — “List of patient education questions to ask your doctor about memory loss and Alzheimer's diagnosis and treatment help.” View full resource at vitals.com
Most Recently Shared on April 18, 2012 at 2:15 pm By:
American Academy of Neurology, and author of A Pocket Guide for the Alzheimer's Caregiver. Additionally, he is a partner at
Alabama Neurology and Sleep Medicine and Associate Clinical Professor at
the University of Alabama’s College of Community Health Sciences.
Selected as the 2008 American Academy of Neurology’s Advocate of the
Year, Dr. Potts seeks to improve the quality of life for dementia
patients and their caregivers primarily through innovative education and
through incorporating the expressive arts. Born out of his experience as
an Alzheimer’s caregiver, and nurtured through the American Academy of
Neurology’s Palatucci Advocacy Program, Dr. Potts formed
Cognitive Dynamics, a foundation dedicated to fostering the
expressive arts to improve the lives of dementia patients and their
caregivers and championing human dignity. Dr. Potts is also Medical Director of a dementia caregiver training caregiver company, Dementia Dynamics, LLC. " /> Daniel C. Potts, MD Doctor, Internist, Neurologist, Physician, and Active Health Library
Memory Loss Patient Education Guide | Alzheimers Treatments
vitals.com — “Visit our patient education guide for a list of memory loss medications and most common Alzheimer's meds and treatments.” View full resource at vitals.com
Most Recently Shared on April 18, 2012 at 2:14 pm By:
American Academy of Neurology, and author of A Pocket Guide for the Alzheimer's Caregiver. Additionally, he is a partner at
Alabama Neurology and Sleep Medicine and Associate Clinical Professor at
the University of Alabama’s College of Community Health Sciences.
Selected as the 2008 American Academy of Neurology’s Advocate of the
Year, Dr. Potts seeks to improve the quality of life for dementia
patients and their caregivers primarily through innovative education and
through incorporating the expressive arts. Born out of his experience as
an Alzheimer’s caregiver, and nurtured through the American Academy of
Neurology’s Palatucci Advocacy Program, Dr. Potts formed
Cognitive Dynamics, a foundation dedicated to fostering the
expressive arts to improve the lives of dementia patients and their
caregivers and championing human dignity. Dr. Potts is also Medical Director of a dementia caregiver training caregiver company, Dementia Dynamics, LLC. " /> Daniel C. Potts, MD Doctor, Internist, Neurologist, Physician, and Active Health Library
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - Celiac.com
celiac.com — “Biopharmaceutical development company, BioLineRx, has announced results from pre-clinical trials which show that their compound, BL-7010, an orally available treatment for celiac disease, reduces the ...” View full resource at celiac.com
Most Recently Shared on April 18, 2012 at 9:19 am By:
csaceliacs Health Organization
Drug May Lower Gluten Toxicity in Patients with Celiac Disease - http://t.co/2y1rcrPk http://t.co/r31MN96a #GF #Celiac
Exploring The Risk And Rewards Of Stem Cell Products
medicalnewstoday.com — “The brave new world of stem cell research dangles the exciting potential for a host of leading-edge treatments that may one day help cure debilitating diseases such as Alzheimer's and Parkinson's,” View full resource at medicalnewstoday.com
Most Recently Shared on April 14, 2012 at 2:23 pm By:
Juan C. Ivancevich, MD Doctor, Internist, Allergist, and Physician
Exploring The Risk And Rewards Of Stem Cell Products. http://t.co/GGq88qVx
FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com
online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.” View full resource at online.wsj.com
Most Recently Shared on April 8, 2012 at 11:34 pm By:
Tom Heston, MD Doctor, Family Medicine Doctor, and Physician
Alzheimer Diagnosis Possible With Scan - Wall Street Journal http://t.co/gle8vhJV #health
Lilly says FDA approves brain imaging agent - Yahoo! News
news.yahoo.com — “From Yahoo! News: Eli Lilly and Co. said late Friday that the Food and Drug Administration approved Amyvid, a diagnostic imaging agent that is intended to help diagnose Alzheimer's disease.” View full resource at news.yahoo.com
Most Recently Shared on April 7, 2012 at 11:39 pm By:
Lilly says FDA approves brain imaging agent: Eli Lilly and Co. said late Friday that the Food and Drug Administr... http://t.co/KiJpJNHt
Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset
fasebj.org — “Epigenetic aberrations in leukocytes of patients with schizophrenia: association of global DNA methylation with antipsychotic drug treatment and disease onset” View full resource at fasebj.org
Most Recently Shared on April 6, 2012 at 5:04 pm By:
Dr Stephen Ayer - Schizophrenia Society of Nova Scotia Health Organization
Epigenetic aberrations in leukocytes of patients with schizophrenia http://t.co/tMWWHHvu
Amgen, AstraZeneca to Work on Inflammation Drugs - WSJ.com
online.wsj.com — “Amgen and AstraZeneca reached a deal to jointly develop and commercialize five inflammatory disease treatments in Amgen's portfolio.” View full resource at online.wsj.com
Most Recently Shared on April 2, 2012 at 9:36 pm By:
Amgen, AstraZeneca to Work on Inflammation Drugs http://t.co/KHcCwwAf
Investigational targeted drug induces responses in aggressive lymphomas, April 2, 2012 News Release - National Institutes of Health (NIH)
nih.gov — “Preliminary results from clinical trials in a subtype of lymphoma show that for a number of patients whose disease was not cured by other treatments, the drug ibrutinib can provide significant anti-cancer responses with modest side effects. These results were presented as part of the opening plenary session at the American Association of Cancer Research (AACR) Annual Meeting 2012 on April 1 by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and coll” View full resource at nih.gov
Most Recently Shared on April 2, 2012 at 1:16 pm By:
News: Investigational targeted drug induces responses in aggressive lymphomas http://t.co/k15ySoFZ
Recent Study Touts Therapy Over Possibly “Harmful” Drugs for Dementia Treatment : Senior Housing News
seniorhousingnews.com — “Many of the delusions suffered by dementia patients may actually have a rational basis, meaning the disease could be more effectively treated through behavioral therapy rather than by psychotropic drugs, suggests the findings of a study published in Psychiatry Research in 2011, according to...” View full resource at seniorhousingnews.com
Most Recently Shared on March 29, 2012 at 7:06 pm By:
Alzheimer's Reading Room is the number one source of life news for the entire Alzheimer's community. Our goal is to Educate, sometimes Entertain, and Empower Alzheimers caregivers and their families worldwide.
" /> Alzheimer's Reading Room Health Advocate
Recent Study Touts Therapy Over Possibly “Harmful” Drugs for Dementia Treatment http://t.co/aLJEyIWZ
Antioxidants may not benefit patients with Alzheimer's disease - - Drug Topics
drugtopics.modernmedicine.com — “Daily supplementation with antioxidants, vitamins E and C, and alpha acid, did not improve memory function in patients with Alzheimer?s disease, according to a new study.” View full resource at drugtopics.modernmedicine.com
Most Recently Shared on March 28, 2012 at 10:31 pm By:
Drugs and Devices OW OW Health
Antioxidants may not benefit patients with Alzheimer's disease: Daily supplementation with antioxidants, v... http://t.co/GlHqXB6Y #drug
Bill proposes modernizing IVD regulations | IVD Technology
ivdtechnology.com — “Congressman Leonard Lance (R-NJ) introduced legislation to promote the development of meaningful treatments for patients with chronic or rare diseases. The “Modernizing Our Drug and Diagnostics Evaluation and Regulatory Network (MODDERN) Cures Act” (HR 3497) would modernize the U.S. drug and diagnostics evaluation and regulatory network by encouraging the discovery and development of new treatments for the many diseases that have few or no options.” View full resource at ivdtechnology.com
Most Recently Shared on March 28, 2012 at 9:09 pm By:
IVD Technology Health Magazine
Bill proposes modernizing IVD regulations http://t.co/hIN3ax1o
Advertisement
Emily Lapkin
@EmilyLapkinOW
Currently, there is no cure for Alzheimer's disease, but drugs are sometimes used to treat Alzheimer symptoms. http://bit.ly/cMoBt2
1 year ago...